Ingevity (NYSE:NGVT – Get Free Report) is scheduled to announce its earnings results after the market closes on Tuesday, October 29th. Analysts expect the company to announce earnings of $0.60 per share for the quarter. Ingevity has set its FY 2024 guidance at EPS.Parties that are interested in participating in the company’s conference call can do so using this link.
Ingevity (NYSE:NGVT – Get Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $1.01 earnings per share for the quarter, missing the consensus estimate of $1.05 by ($0.04). The business had revenue of $390.60 million during the quarter, compared to analysts’ expectations of $407.58 million. Ingevity had a positive return on equity of 19.59% and a negative net margin of 27.85%. The company’s revenue was down 18.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.41 earnings per share. On average, analysts expect Ingevity to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Ingevity Trading Up 4.5 %
Shares of Ingevity stock opened at $33.65 on Friday. The firm has a market capitalization of $1.22 billion, a price-to-earnings ratio of -2.83 and a beta of 1.62. Ingevity has a fifty-two week low of $30.90 and a fifty-two week high of $56.29. The company has a debt-to-equity ratio of 4.92, a quick ratio of 1.07 and a current ratio of 1.92. The stock has a 50 day moving average of $36.67 and a 200 day moving average of $42.61.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Analysis on NGVT
About Ingevity
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.
Featured Articles
- Five stocks we like better than Ingevity
- 5 discounted opportunities for dividend growth investors
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Find and Profitably Trade Stocks at 52-Week Lows
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- How to invest in marijuana stocks in 7 steps
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.